{"result": "(\"entity\"<|>HIPÓFISIS<|>GEO<|>The hipófisis is a gland in the brain that plays a crucial role in hormone regulation and is suspected to be involved in the patient's condition of adrenal insufficiency.)\n##\n(\"entity\"<|>ENFERMEDAD ADDISON<|>EVENT<|>Addison's disease is a condition characterized by insufficient production of hormones by the adrenal glands, leading to symptoms such as hypoglycemia and fatigue.)\n##\n(\"entity\"<|>NEUROSARCOIDOSIS<|>EVENT<|>Neurosarcoidosis is a rare condition where sarcoidosis affects the nervous system, which is considered in the differential diagnosis of the patient's symptoms.)\n##\n(\"entity\"<|>INSUFICIENCIA SUPRARENAL<|>EVENT<|>Adrenal insufficiency is a condition where the adrenal glands do not produce adequate amounts of steroid hormones, leading to various clinical symptoms.)\n##\n(\"entity\"<|>ACTH<|>PERSON<|>Adrenocorticotropic hormone (ACTH) is a hormone produced by the pituitary gland that stimulates the adrenal glands to release cortisol, and its deficiency is suspected in the patient.)\n##\n(\"entity\"<|>CORTISOL<|>PERSON<|>Cortisol is a steroid hormone produced by the adrenal glands, and its low levels are indicative of adrenal insufficiency in the patient.)\n##\n(\"entity\"<|>Bocio<|>EVENT<|>Goiter is an enlargement of the thyroid gland, which may indicate underlying autoimmune conditions such as Hashimoto's disease in the patient.)\n##\n(\"relationship\"<|>HIPÓFISIS<|>INSUFICIENCIA SUPRARENAL<|>The hipófisis is involved in the regulation of ACTH, which is crucial for adrenal function, thus linking it to adrenal insufficiency<|>8)\n##\n(\"relationship\"<|>ENFERMEDAD ADDISON<|>INSUFICIENCIA SUPRARENAL<|>Addison's disease is a specific type of adrenal insufficiency<|>9)\n##\n(\"relationship\"<|>NEUROSARCOIDOSIS<|>HIPÓFISIS<|>Neurosarcoidosis may affect the pituitary gland, leading to hormonal imbalances<|>4)\n##\n(\"relationship\"<|>ACTH<|>INSUFICIENCIA SUPRARENAL<|>ACTH deficiency is a key factor in the development of adrenal insufficiency<|>9)\n##\n(\"relationship\"<|>CORTISOL<|>INSUFICIENCIA SUPRARENAL<|>Low cortisol levels are a direct indicator of adrenal insufficiency<|>9)\n##\n(\"relationship\"<|>Bocio<|>HIPÓFISIS<|>The presence of goiter may suggest an underlying autoimmune condition affecting the pituitary gland<|>3)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: extremo, o idiopático (ancianos).\n\nLos fármacos son una causa frecuente de SIADH, principalmente los psicótropos y quimioterápicos. Algunos producen SIADH por estimulación directa de la liberación de vasopresina, y otros por aumento de su acción.\n\nLos fármacos más habitualmente relacionados con el SIADH serían:\n\n- Antidepresivos: inhibidores selectivos de la recaptación de serotonina, tricíclicos, inhibidores de la monoaminooxidasa, venlafaxina.\n- Antiepilépticos: carbamacepina, valproato, lamotrigina.\n- Antipsicóticos: fenotiazinas, butirofenonas.\n- Quimioterápicos: alcaloides derivados de la vinca, platino, ifosfamida, melfalán, ciclofosfamida, metotrexato, pentostatina.\n- Antidiabéticos: clorpropamida, tolbutamida.\n- Análogos de vasopresina: desmopresina, oxitocina, terlipresina, vasopresina.\n- Miscelánea: opiáceos, éxtasis, levamisol, AINE, clofibrato, nicotina, amiodarona, inhibidores de la bomba de protones, anticuerpos monoclonales.\n\n## 1.11 Casos clínicos. Caso clínico 1\n\n### 58. La forma de presentación del cuadro clínico le parece compatible con:\n\nA. Tumoración hipofisaria.\nB. Enfermedad Addison.\nC. Neurosarcoidosis.\nD. Hipofisitis autoinmune.\n\n### COMENTARIO\n\nLa paciente presenta clínica (hipoglucemia y astenia) y datos bioquímicos (cortisol bajo) compatibles con insuficiencia suprarrenal.\n\nPara diferenciar si se trata de una insuficiencia suprarrenal primaria o secundaria, el dato que nos puede orientar en este caso es la coloración de la piel. Si se tratase de una enfermedad de Addison o insuficiencia adrenal primaria, lo esperable sería encontrar hiperpigmentación cutáneo-mucosa. Esto hace que nos inclinemos por una insuficiencia suprarrenal secundaria, es decir, por déficit de ACTH. Por tanto, descartaríamos la opción B.\n\nEl resto de las opciones entrarían en el diagnóstico diferencial de la insuficiencia suprarrenal secundaria. Pero el patrón hormonal que tiene la paciente también es útil en el diagnóstico diferencial.\n\nA pesar de tener un déficit de ACTH, los ejes tiroideo y gonadotropo de la paciente son normales (el eje somatotropo no se ha valorado). Si se tratase de un tumor hipofisario, el déficit de ACTH sería uno de los más tardíos en aparecer, y los iniciales serían el déficit de gonadotropinas y de GH. En las hipofisitis, el patrón de aparición de los déficits hormonales es contrario al de los adenomas hipofisarios: ACTH > TSH > LH/FSH > PRL > GH.\n\nPor este motivo, descartamos la opción de tumoración hipofisaria y sospecharíamos un proceso inflamatorio de la hipófisis o hipofisitis.\n---\n# HIPÓFISIS\n\nPor último, el perfil de la paciente: mujer, joven, con probable patología autoinmunitaria de base (tiene un bocio y antecedentes familiares de Hashimoto), nos hace sospechar una hipofisitis autoinmune. La posibilidad de que se trate de una hipofisitis secundaria a neurosarcoidosis sería más remota, ya que nada en el caso sugiere esta enfermedad sistémica.\n\nReferencias:\n- Aulinas A, Webb S, Resmini E. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición; 2015. Capítulo 14. Hipofisitis [citado 29 de abril de 2019]. Disponible en: https://manual.seen.es/article?id=55114b8d-4ef4-49ad-8aab-2bcdac18103c\n\n## 59 ¿Cuál de las siguientes determinaciones le daría más información de cara al tratamiento?\n\nA. Cortisol tras hipoglucemia insulínica.\nB. IGF 1.\nC. ACTH basal.\nD. Ac. Anti-TPO.\n\n### COMENTARIO\n\nLa paciente tiene sospecha clínica y bioquímica de insuficiencia suprarrenal secundaria y lo fundamental será confirmar este diagnóstico e iniciar el tratamiento.\n\nA diferencia de los ejes tiroideo, gonadal y lactotropo, que solo suelen requerir determinaciones basales para el diagnóstico de los correspondientes déficits, los ejes somatotropo y corticotropo precisan habitualmente de pruebas funcionales dinámicas para evaluar la reserva hipofisaria.\n\nLas cifras de cortisol entre 3,6 y\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}